Skip to content

Abbott ABT EV / EBITDA

EV / EBITDA at other companies

Becton, Dickinson and Company logo
Becton, Dickinson and CompanyBDX
12.3×-6.5×
Johnson & Johnson logo
Johnson & JohnsonJNJ
18.8×+4.2×
Boston Scientific logo
Boston ScientificBSX
28.3×-8.5×
DexCom logo
DexComDXCM
17.9×-12.4×
Edwards Lifesciences logo
Edwards LifesciencesEW
29.5×+4.1×
Medtronic logo
MedtronicMDT
13.9×-1.5×

Other financials

Income statement

See full
Revenue$11.2B+7.8%
Gross profit$6.3B+6.5%
Operating income$1.3B-20.6%
Net income$1.1B-18.7%
EPS (diluted)$0.61-19.7%

Balance sheet

See full
Cash & equivalents$6.8B+4.2%
Total debt$34.0B+157%
Total equity$52.1B+6.7%
Total assets$110.43B+35.6%

Cash flow

See full
Operating cash flow$1.3B-7.2%
CapEx$399.0M-17.6%
Free cash flow$916.0M-1.8%

Valuation

See full
Market cap$154.15B-22.5%
Enterprise value$181.39B-13.1%
P/E24.6×+9.8×
P/S3.4×-1.3×

Profitability

See full
Gross margin56.3%+0.4pp
Operating margin17.1%+0.2pp
Net margin13.9%-18.0pp

Returns & leverage

See full
Return on equity12.4%-18.4pp
Debt / equity0.7×+0.4×
Current ratio1.4×-0.4×

Where this comes from

Calculated from Abbott’s reported figures.

Based on the most recent quarter.

The official record: Abbott’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Abbott's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Abbott's EV / EBITDA?
Abbott (ABT) reported EV / EBITDA of 18.9× in Q1 2026.
How has Abbott's EV / EBITDA changed year-over-year?
Abbott's EV / EBITDA decreased by 17.7% year-over-year, from 23× to 18.9×.
What is the long-term trend for Abbott's EV / EBITDA?
Over 4 years (2021 to 2025), Abbott's EV / EBITDA has grown at a 2.1% compound annual growth rate (CAGR), from 81.1× to 88.1×.
What does EV / EBITDA mean?
What the whole business (debt included) costs relative to its operating cash earnings.
How do you interpret EV / EBITDA?
Lets you compare companies with different leverage and tax positions on a like-for-like basis — the standard multiple in M&A. Lower can mean cheaper, subject to growth and capital intensity.
How does EV / EBITDA compare across companies?
Broadly comparable across non-financial sectors; not used for banks and insurers, where EBITDA is not meaningful.